Vogo 0.2 Tablet
Marketer
Alembic Pharmaceuticals Ltd
Salt Composition
Voglibose (0.2mg)
Overview Vogo 0.2 Tablet
DiaVance 0.2mg tablets are indicated for the management of type 2 diabetes. This medication assists in regulating elevated postprandial blood glucose. It's prescribed when dietary modifications and other comparable therapies prove insufficient to manage hyperglycemia. DiaVance 0.2mg should be administered immediately prior to meals. Dosage frequency is determined individually by your physician to optimize glycemic control. Discontinuation should only occur under medical supervision; abrupt cessation may elevate blood sugar, potentially leading to severe complications such as nephropathy or vision impairment. This medication forms part of a comprehensive treatment plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is crucial during treatment. Commonly reported adverse effects include abdominal discomfort, gas, appetite suppression, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While DiaVance 0.2mg alone doesn't induce hypoglycemia, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Hypoglycemic episodes require treatment with plain glucose; sucrose is ineffective in this context. Inform your physician of any pre-existing hepatic or renal conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease, ulcerative colitis). Pregnant or lactating individuals should seek medical advice prior to use. Always disclose all other medications to ensure medication safety. Excessive alcohol consumption should be avoided due to the increased risk of hypoglycemia.
Uses of Vogo 0.2 Tablet
Managing type 2 diabetes
Major Benefits of Vogo 0.2 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vogo 0.2 Tablet on an empty stomach.
Common Side effects of Vogo 0.2 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vogo 0.2 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vogo 0.2 Tablet should be administered on an empty stomach.
How Vogo 0.2 Tablet works:
Vogo 0.2mg tablets are used to manage diabetes. Their mechanism involves blocking the activity of intestinal enzymes that digest complex carbohydrates into glucose. This action helps prevent post-meal spikes in blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vogo 0.2 Tablet with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
Use of Vogo 0.2 Tablet during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; human data on this, however, remains scarce.
Breast feedingSAFE IF PRESCRIBED
Using Vogo 0.2 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vogo 0.2 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Vogo 0.2 Tablet. Dosage modification of Vogo 0.2 Tablet might be necessary; physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Vogo 0.2 Tablet. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Vogo 0.2 Tablet :
Omit any missed Vogo 0.2 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Vogo 0.2 Tablet
Label | Value |
---|---|
Type of Compound | A compound derived from valiolamine. |
Potential for Dependence | None. |
Type of Medication | Medication for diabetes |
Mechanism of Action | Agents that inhibit alpha-glucosidase |